Chembio Diagnostics Inc. buy melinda
Start price
05.07.17
/
50%
€5.55
Target price
13.11.17
€6.13
Performance (%)
7.32%
End price
13.11.17
€5.95
Summary
This prediction ended on 13.11.17 with a price of €5.95. With a performance of 7.32%, the BUY prediction by melinda for Chembio Diagnostics Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Chembio Diagnostics Inc. | - | - | - | - |
iShares Core DAX® | 0.786% | 1.251% | 11.561% | 16.636% |
iShares Nasdaq 100 | 1.855% | -2.687% | 25.316% | 43.346% |
iShares Nikkei 225® | 3.947% | 2.199% | 11.527% | 12.586% |
iShares S&P 500 | 1.787% | 0.151% | 23.699% | 42.958% |
Comments by melinda for this prediction
In the thread Chembio Diagn.new diskutieren
Chembio
5. Juli (Reuters) - Chembio Diagnostics Inc: das System der Chembio DPP® zika, einschließlich der Mikrolauf DPP® von der Aufsichtsbehörde für Gesundheit von Brasilien zugelassen. Diagnosetests - Empfangene Zulassung für die kommerzielle Nutzung in Brasilien des Microdrive DPP durch ANVISA in Zusammenarbeit mit Bio-Manguinhos / Fiocruz.
(Vom Mitglied beendet)
Stopped prediction by melinda for Chembio Diagnostics Inc.
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€3.32
09.09.20
09.09.20
€5.00
04.11.21
04.11.21
-44.28%
05.11.21
05.11.21
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€4.20
23.07.20
23.07.20
€8.00
09.09.20
09.09.20
-20.95%
09.09.20
09.09.20
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€6.36
02.12.18
02.12.18
€6.77
22.01.19
22.01.19
-0.43%
22.01.19
22.01.19
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€6.36
28.02.18
28.02.18
€7.04
09.03.18
09.03.18
10.83%
09.03.18
09.03.18
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€6.15
05.07.17
05.07.17
€6.80
13.11.17
13.11.17
7.32%
13.11.17
13.11.17